BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9781906)

  • 1. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.
    Beckwith JB
    Am J Med Genet; 1998 Oct; 79(4):268-73. PubMed ID: 9781906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precursor lesions of Wilms tumor: clinical and biological implications.
    Beckwith JB
    Med Pediatr Oncol; 1993; 21(3):158-68. PubMed ID: 8383276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
    Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
    Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors.
    Fukuzawa R; Reeve AE
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):589-94. PubMed ID: 17805030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.
    Beckwith JB; Kiviat NB; Bonadio JF
    Pediatr Pathol; 1990; 10(1-2):1-36. PubMed ID: 2156243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
    Heppe RK; Koyle MA; Beckwith JB
    J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms tumor: an update.
    Al-Hussain T; Ali A; Akhtar M
    Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perilobar nephrogenic rests and chromosome 22.
    Mdzin R; Phillips M; Edwards C; Murch A; Charles A
    Pediatr Dev Pathol; 2011; 14(6):485-92. PubMed ID: 21864120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
    Fukuzawa R; Heathcott RW; More HE; Reeve AE
    J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
    Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
    Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrogenic rests and nephroblastomatosis].
    Perlman E; Dijoud F; Boccon-Gibod L
    Ann Pathol; 2004 Dec; 24(6):510-5. PubMed ID: 15785399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
    Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
    Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of nephrogenic rests and nephroblastomatosis.
    Hennigar RA; O'Shea PA; Grattan-Smith JD
    Adv Anat Pathol; 2001 Sep; 8(5):276-89. PubMed ID: 11556536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
    Muir TE; Cheville JC; Lager DJ
    Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.